How much does it cost for a patient to take bedaquiline for 6 months?
Bedaquiline (Bedaquiline) is a tuberculosis drug containing the active substance bedaquiline. Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. Bedaquiline can be used in combination with other TB drugs in adults and children (5 years and older, weighing at least 15 kg) with pulmonary TB who are resistant to at least two standard TB drugs, isoniazid and rifampicin.
Bedaquiline is available by prescription only, and treatment should be initiated and monitored by a physician experienced in treating tuberculosis that is resistant to at least isoniazid and rifampicin. In addition, medical staff observe patients while they take their medications. Bedaquiline is available as a tablet and should be taken with food. For adults, 400 mg once daily for the first two weeks, then 200 mg three times a week for the next 22 weeks. For children, the dosage is based on the child's weight.
In China, bedaquiline is marketed as bedaquiline fumarate tablets. The common specifications are100mg*24 tablets per box, and the price is about 10,000 yuan. It is estimated that the cost for adult patients to take bedaquiline for 6 months is about 100,000 yuan, which is relatively high. However, bedaquiline has been included in the scope of medical insurance, and the actual burden on patients will be reduced after reimbursement.
In comparison, the price of the Russian version of bedaquiline (specification100mg*188 tablets per box) sold overseas is about 15,000 yuan, but due to exchange rate fluctuations, the actual price may change. Overall, it is estimated that the cost for adult patients to use bedaquiline for 6 months overseas is about 20,000 yuan, which is cheaper than domestic prices.
It is worth noting that the ingredients of bedaquiline sold at home and abroad are basically the same, and there are currently no generic bedaquiline drugs produced and marketed overseas. Therefore, patients should fully consider the price of the drug, medical insurance reimbursement status, and doctor's advice when choosing a treatment plan.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)